🇺🇸 FDA
Patent

US 8211941

Antagonists of the transient receptor potential vanilloid 1 and uses thereof

granted A61KA61K31/519A61K31/551

Quick answer

US patent 8211941 (Antagonists of the transient receptor potential vanilloid 1 and uses thereof) held by The Board of Regents of the University of Texas System expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/519, A61K31/551